Picture of RTW Biotech Opportunities logo

RTW — RTW Biotech Opportunities News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeMid CapNeutral

RTW Biotech Opp. - Director/PDMR Shareholding

RNS Number : 9591P

RTW Biotech Opportunities Ltd

22 January 2026

 

RTW BIOTECH OPPORTUNITIES LTD

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

The Company announces that Nicola Blackwood, non-executive director, purchased an aggregate of 23,373 shares in the fourth quarter of 2025. Due to an oversight these purchases were not notified to the Company and therefore not disclosed publicly. As soon as this oversight was identified the situation was rectified immediately Details of the purchases are set out below.

 

1Details of the person discharging managerial responsibilities / person closely associated
a)NameNicola Blackwood
2Reason for the notification
a)Position/statusDirector
b)Initial notification /AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameRTW Biotech Opportunities Ltd
b)LEI549300Q7EXQQH6KF7Z84
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument
Identification code
Ordinary shares of no par value
GG00BKTRRM22
b)Nature of the transactionPurchase of Shares
c)Price(s) and volume(s)
Price(s)Volume(s)
$1.5585
$2.18844
16,493
6,880
d)Aggregated information
- Aggregated volume
- Price
23,373
$1.7439
e)Date of the transaction6 October 2025 and 23 December 2025
f)Place of the transactionLondon Stock Exchange
  This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     DSHAKBBPCBKKKDB

Recent news on RTW Biotech Opportunities

See all news